[Form 4] Magnera Corp Insider Trading Activity

Rhea-AI Filing Summary

Magnera Corp (MAGN) director Thomas E. Salmon reported acquiring 9,501 shares of common stock on 11/04/2025 through an RSU-related transaction coded M.

Following the transaction, he holds 9,501 shares directly and 35,289 shares indirectly via The Thomas E. Salmon Revocable Living Trust. The common stock line lists a price of $8.53, while the derivative RSU entry shows a price of $0 and a remaining balance of 0 derivative securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Salmon Tom

(Last) (First) (Middle)

9335 HARRIS CORNERS PKWY

SUITE 300

(Street)

CHARLOTTE NC 28269

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Magnera Corp [ MAGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $.01	11/04/2025		M		9,501	A	$8.53	9,501	D
Common Stock, Par Value $.01								35,289	I	The Thomas E. Salmon Revocable Living Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	11/04/2025		M			9,501	11/04/2025(3)	11/04/2025	Common Stock, Par Value $.01	9,501	$0	0	D

Explanation of Responses:

1. Represents shares of Issuer common stock held by The Thomas E. Salmon Revocable Living Trust, of which the reporting person and his wife are beneficiaries and serve as trustees.

2. Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date.

3. This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date.

	/s/ Laura A. Jones, attorney-in-fact for Thomas Salmon	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MAGN director Thomas Salmon report on Form 4?

He reported acquiring 9,501 shares of Magnera Corp common stock on 11/04/2025 via a transaction coded M related to RSUs.

How many MAGN shares does Thomas Salmon own after the transaction?

He owns 9,501 shares directly and 35,289 shares indirectly through a revocable living trust.

What prices are shown for the RSU and common stock entries?

The common stock entry lists $8.53; the derivative RSU entry lists $0 and shows 0 derivatives remaining.

What does transaction code M indicate in this context?

Code M denotes a conversion or exercise of a derivative security, here tied to restricted stock units (RSUs).

Who holds the indirect MAGN shares for Thomas Salmon?

The indirect 35,289 shares are held by The Thomas E. Salmon Revocable Living Trust.

When do the FY2025 director RSUs vest?

The filing states the FY2025 director grant vests in full and all restrictions lapse one year from the Grant Date.